Federal Signal [FSS]
The memo issues NO position verdict. It scores Criteria and hands the book an analysis.
| criterion | verdict | basis |
|---|---|---|
| Quality | PASS | 14 consecutive profitable years; operating margin 6.4% (2012) → 16.0% (TTM) on a monotone uptrend; ROIC 14.85% (31.8% ex-goodwill) — the best in this cluster; no customer at 10% of sales, explicitly disclosed |
| Accounting quality | PASS | DPO SHORTENED 5.0 days while revenue grew 34.9% — the strongest cash-quality result in the cluster and the inverse of the CLS pattern; explicit factoring search returned nil. DSO +1.3 days is the one blemish and is partly acquired balance sheets consolidating |
| Growth durability | FAIL | backlog −5.9% (Q1'26 $1,037.5m vs Q1'25 $1,102.0m) while revenue rose 34.9%; book-to-bill 0.996 vs 1.224; ESG order growth explicitly includes "the acquisition of a $15.8 million U.S. order backlog"; the backlog is structurally "two to three months of shipments" |
| Valuation (implied-path test) | FAIL | required 19.0% vs ~10.0% demonstrated organic; −9.0pp. But it crosses to PASS at a ~16.5x exit multiple, the least punishing crossover in the cluster |
| Catalyst | PASS | Q2 2026 results imminent — not yet filed as of 2026-07-30, prior-year comparable filed 2025-07-30 |
| Capital allocation | INDETERMINATE | ROIC 14.85% well above an 8.5% WACC, which is a PASS on returns. But $501.0m of FY2025 acquisition spend is disclosed without any revenue, EBITDA or multiple for the targets, so the return on the marginal capital allocated cannot be evaluated. A missing input is INDETERMINATE, never FAIL |
Equity. Default under the brief; needs no argument. Realised 252-day volatility is 38.4%, which is high relative to the fundamentals (1.06x net leverage, municipal demand) and reflects a $7.4bn float. No LEAP is proposed: the IV−RV spread was not measured this run and the brief requires it measured, not assumed.
No entry is written to trade_recommendations.jsonl — the valuation output is a FAIL.
| Thesis | an operating-quality name at a fair price with a deteriorating order book. The 14.85% ROIC and +5.8% 90-day EPS revisions are the case; the −5.9% backlog and 0.996 book-to-bill are the case against |
| Horizon | 12 months |
| Size | 38.4% realised vol argues for a half-to-three-quarter weight slot despite modest leverage |
| Entry | none proposed — the five-year test is a FAIL |
| Invalidation, hard | Q2 2026 book-to-bill below 1.0 for a second consecutive quarter, or consolidated backlog below $1.0bn. Two consecutive sub-1.0 quarters with backlog through $1.0bn converts "one tough comparison" into a trend |
| Invalidation, soft | ESG aftermarket falling below 19% of segment revenue (from 20.05%, was 22.15%); gross margin below 27.5% |
| Downside case, named cause | The backlog decline is real and Q2 confirms it, while the acquired revenue annualises away. Q1'26's +34.9% becomes a low-single-digit number in mid-2027 once New Way, Kinloch and Mega are in both periods, and the aftermarket mix has not yet recovered because the installed base is too young. On that path the multiple reverts to the six-year median 2.89x, giving $121.42, −0.3% to spot on the same NTM revenue. Type: MEASURED — logged and scored, does not reject the name |
A disclosed organic growth rate. Federal Signal's demonstrated growth is the single input this memo could not measure — it is an estimate bounded at 9.5%–11.3% because the company publishes no organic figure and no ASC 805 supplemental pro forma revenue for a $424.2m acquisition. If organic growth is disclosed at the top of that range and backlog turns, the crossover to PASS is only ~16.5x of exit multiple away — the narrowest gap of the three names underwritten in this cluster.